• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Mediterranean diet may reduce the incidence of breast cancer

byShayna BejaimalandJames Jiang
September 17, 2015
in Chronic Disease, Obstetrics, Oncology
Reading Time: 3 mins read
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Share on FacebookShare on Twitter

 

1. This secondary analysis of the data from the PREDIMED trial found that there was a 70% decrease in breast cancer incidence for women randomized to Mediterranean diet supplemented with extra-virgin olive oil.

2. There was a non-significant reduction in breast cancer incidence in women who were randomized to the Mediterranean diet supplemented with nuts.

Evidence Rating Level: 1 (Excellent)

Study Rundown: The incidence of breast cancer is increasing worldwide: from 2008 to 2012 there was a 20% increase in incidence, accompanied by a 14% increase in mortality. Previous epidemiological studies have identified diet as a potential modifiable risk factor in breast cancer development however no controlled studies have been performed. The Mediterranean diet (MeDiet) in particular has garnered attention, as breast cancer incidence has historically been lower in Mediterranean countries as compared to North America and Central Europe. This secondary analysis of a randomized controlled trial, which was originally conducted to examine cardiovascular disease, was aimed to examine the effects of the MeDiet supplemented with extra-virgin olive oil or nuts on the incidence of breast cancer in women.

Mediterranean diet supplemented with extra-virgin olive oil was statistically associated with an approximately 70% reduction in breast cancer incidence. There was a non-significant reduction in breast cancer incidence in women who were randomized to the Mediterranean diet supplemented with mixed nuts. The strengths of this study include its randomized design and adjustment of hazard ratios with many relevant potential confounders. However, the number of observed breast cancers was small and thus may impact the power of the study to detect a reduction in breast cancer incidence. Moreover, this was a secondary analysis of data collected for the PREDIMED trial, which was not powered to detect breast cancer, but rather cardiovascular disease.

RELATED REPORTS

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

2 Minute Medicine Rewind August 10, 2026

Click to read the study in JAMA Internal Medicine

Relevant Reading: Moderate alcohol consumption during adult life, drinking patterns and breast cancer risk

In-Depth [randomized controlled trial]: This 1:1:1 randomized, single-blind controlled trial was conducted at primary health care centres across Spain from 2003 to 2009, originally designed to examine cardiovascular disease. It included 4,282 women aged 60 to 80 years old at high risk for cardiovascular disease. These women were randomized to either a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a control diet with advice to reduce dietary fat. The outcome of interest was breast cancer incidence in women without a prior history of breast cancer. Intention-to-treat analysis using multivariable Cox regression adjusted for many variables (including age, recruitment centre, baseline BMI, use of hormone therapy, family history of cancer and physical activity) was used.

In total, 4152 women were analyzed for breast cancer incidence. After a median of 4.8 years of follow-up, 35 new cases of breast cancer were identified. The Mediterranean diet supplemented with olive oil had an almost 70% decrease in breast cancer incidence: multivariable-adjusted hazard ratio vs. control group was 0.32 (95% CI 0.13-0.79). There was a non-significant relationship between the Mediterranean diet supplemented with mixed nuts group as compared to control (adjusted HR 0.59, 95% CI 0.26-1.35).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancer
Previous Post

Medicare may need additional information to determine expected hospital readmission rates

Next Post

Susceptibility-weighted imaging improves diagnostic accuracy of rotator cuff tendonitis

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026
Next Post
Time from symptom onset may not predict infarct volume in stroke

Susceptibility-weighted imaging improves diagnostic accuracy of rotator cuff tendonitis

Late gestation antidepressant use linked to postpartum hemorrhage

Late gestation antidepressant use linked to postpartum hemorrhage

Nivolumab may be effective in platinum-resistant ovarian cancer

Nivolumab may be effective in platinum-resistant ovarian cancer

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A machine-learning diet score identifies eating patterns associated with lower aging-related mortality
  • Deep-learning model achieved high diagnostic performance for detecting cardiac enlargement using electrocardiograms
  • Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.